Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Biological Chemistry|March 21, 2012
Modulation of the Pyrococcus abyssi NucS endonuclease activity by replication clamp at functional and structural levelsChristophe Creze, Alessio Ligabue, Sébastien Laurent, et al.Journal of Inorganic Biochemistry|December 18, 2007
Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cellsGaetano Marverti, Matteo Cusumano, Alessio Ligabue, et al.Gynecologic Oncology|December 25, 2009
Spermidine/spermine N1-acetyltranferase modulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistant human ovarian cancer cell linesGaetano Marverti, Alessio Ligabue, Davide Guerrieri, et al.Bioorganic & Medicinal Chemistry|October 19, 2010
Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitorsEmanuele Carosati, Gianluca Sforna, Massimiliano Pippi, et al.European Journal of Pharmacology|May 19, 2009
Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cellsGaetano Marverti, Alessio Ligabue, Giuseppe Paglietti, et al.Scientific Reports|April 19, 2016
Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclusteringOlga Blaževitš, Yonatan G Mideksa, Maja Šolman, et al.Elife|August 15, 2015
Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentationMaja Šolman, Alessio Ligabue, Olga Blaževitš, et al.Investigational New Drugs|October 17, 2009
Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and -resistant human ovarian cancer cellsGaetano Marverti, Alessio Ligabue, Monica Montanari, et al.Proceedings of the National Academy of Sciences of the United States of America|July 29, 2011
Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthaseDaniela Cardinale, Giambattista Guaitoli, Donatella Tondi, et al.Pageof 2